Ebola

Latest News

Johnson & Johnson Ranks #4 on Fortune’s Return on Leadership List

For more than a century, Johnson & Johnson has used a core set of values to help build its business. Now, that sense of purpose has landed it on the Fortune ROL100, a new ranking of corporate leadership.

ON NOW

Our Heritage

6 Trailblazing Johnson & Johnson Scientists Past and Present

For Women's History Month, we're spotlighting three of the company's pioneering early female scientists—and their modern-day counterparts, who are not only innovating in the lab, but also paving the way for the next generation of powerhouse women.

ON NOW

Latest News

8 Things to Know About Johnson & Johnson's Janssen COVID-19 Vaccine

As the company announces that its single-dose Janssen COVID-19 Vaccine has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, here are some key facts about how it works (hint: it involves an inactivated common cold virus), how it has been studied, how it would be transported—and more.

ON NOW

Latest News

4 Ways Johnson & Johnson Has Worked to Make Access to Medicines Around the World More Equitable

The Access to Medicine Index, a ranking of pharmaceutical companies' work to distribute medications to low- and middle-income countries, just named Johnson & Johnson #3 on its biennial list, underscoring the company's deep history of ensuring people in underserved communities receive the treatments they need.

ON NOW

Innovation

"My 2021 Healthcare Resolution": 7 Johnson & Johnson Leaders Share Their Goals for Advancing Healthcare and Health Equity

A potential COVID-19 vaccine. Passionate efforts toward achieving racial and social justice. Smarter, more sustainable product packaging. These are just a few of the resolutions company change makers are aiming to bring to light this year—and they're already hard at work on them.

ON NOW

Latest News

The Impact of COVID-19 on a Company: 6 Questions for the Chief Financial Officer of Johnson & Johnson

When you're the CFO of a company, you have a holistic view of how a pandemic can touch every aspect of a business, especially when it's a healthcare company. So we posed inquiring mind questions to Joe Wolk about what the past eight months have been like for him at the financial helm of the company—via a Zoom interview.

ON NOW

Our Heritage

4 Innovative Ways Johnson & Johnson Has Helped Protect the Public's Health During Outbreaks Since the Late 1800s

From epidemic masks that the company introduced during the Spanish flu pandemic to work it's doing today on an investigational COVID-19 vaccine, learn how the company has been at the forefront of safeguarding global public health for well over a century.

ON NOW

Latest News

Johnson & Johnson Named to Fast Company's 2020 Best Workplaces for Innovators List

The company is proud to have made the list for the second year in a row. From its work on an Ebola vaccine—and an investigational COVID-19 vaccine—to collaboration taking place across its Johnson & Johnson Innovation centers, we take a look at the innovative spirit that permeates the company's culture.

ON NOW

Latest News

5 Facts About Johnson & Johnson’s Investigational Janssen COVID-19 Vaccine Candidate

With its global Phase 3 clinical trial now fully enrolled with approximately 45,000 adult participants, we share the most up-to-date information about the single-dose investigational vaccine candidate.

ON NOW

Latest News

Johnson & Johnson and Its Partners Mark a Milestone in the Quest for a Global Preventive HIV Vaccine With the Imbokodo Study

The clinical trial has completed full immunizations of the company's investigational HIV vaccine regimen. Learn what this means for the future of fighting the disease—and also for the creation of a potential vaccine for COVID-19.

ON NOW

Latest News

6 Latest Facts About Johnson & Johnson's Ebola Vaccine

In response to a new Ebola outbreak in Guinea, Johnson & Johnson is providing up to 200,000 doses of its Ebola vaccine regimen to the country for a World Health Organization supported clinical trial. Learn more about the initiative and other top facts about the vaccine regimen for the deadly virus.

ON NOW

Hanneke Schuitemaker, Ph.D., Global Head of Viral Vaccine Discovery and Translational Medicine and the Disease Area Stronghold Leader for Viral Vaccines at Janssen Vaccines & Prevention, a Janssen Pharmaceutical Company of Johnson & Johnson

Innovation

She's a Scientist with One of the World's Most Important Jobs: Creating a Potential COVID-19 Vaccine

Imagine being a researcher who is staring down not only a highly infectious virus, but one that's caused the first global pandemic in more than 100 years. Meet Johnson & Johnson's Hanneke Schuitemaker, Ph.D.

ON NOW

A close-up view of a microscope and a hand

Innovation

“I’m a Scientist Working on a Potential COVID-19 Vaccine”: Meet a Researcher Who's Studying a Promising Candidate

Roland Zahn, Ph.D., a Janssen scientist and expert in viral vaccines, was at the front lines of research during the Ebola outbreak. Today he and his team are working at record speed to help deliver a potential vaccine for the novel coronavirus.

ON NOW

Latest News

What You Need to Know About the Coronavirus—and a Potential Preventive Vaccine

The coronavirus has made headlines as it has spread from China to other parts of the world. To help stop the global outbreak in its tracks, Johnson & Johnson is already hard at work on a potential preventive vaccine.

ON NOW

Collage depicting innovations from Johnson & Johnson around Ebola, bladder cancer, HIV and more

Latest News

Johnson & Johnson Named a 2020 Fortune World’s Most Admired Company

Innovativeness and a commitment to social responsibility are just some of the respected attributes that helped the company land on the prestigious list for another year.

Internet Explorer is no longer supported by this website.

Ebola